London · Delayed Price · Currency is GBP · Price in GBX Hikma Pharmaceuticals Company Description
Hikma Pharmaceuticals PLC develops, manufactures, markets, and sells a range of generic, specialty, and branded pharmaceutical products.
The company operates through three segments: Injectables, Hikma Rx, and Branded. The Injectables segment provides generic and specialty injectable products primarily for use in hospitals.
The Branded segment offers branded generics and in-licensed products to retail and hospital markets. The Hikma Rx segment offers oral, respiratory, and other generic and specialty products for the retail market.
It provides its products in various therapeutic areas, including respiratory, oncology, and pain management.
The company also offers its products in solid, semi-solid, liquid, and injectable dosage forms. It operates in the United Kingdom, Europe, North America, the Middle East, North Africa, and internationally.
Hikma Pharmaceuticals PLC was founded in 1978 and is headquartered in London, United Kingdom.
| Country | United Kingdom |
| Founded | 1978 |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector | Healthcare |
| Employees | 9,400 |
| CEO | Said Samih Darwazah |
Contact Details
Address: 1 New Burlington Place London, W1S 2HR United Kingdom | |
| Phone | 44 20 7399 2760 |
| Website | hikma.com |
Stock Details
| Ticker Symbol | HIK |
| Exchange | London Stock Exchange |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| ISIN Number | GB00B0LCW083 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Khalid Walid Hussni Al Nabilsi CPA | Deputy Chief Executive Officer of North America and Europe and Director |
| Mazen Samih Taleb Darwazah | Executive Vice Chairman and Deputy Chief Executive Officer of MENA |
| H.E Said Samih Taleb Darwazah | Chief Executive Officer |
| Areb AL KURDI | Vice President, Group Financial Controller and Acting Chief Financial Officer |
| Patricia Bousfield | Chief Information Officer |
| Guy Featherstone | Associate Director of Investor Relations |
| Samuel Park | General Counsel |
| Bassam Wael Rushdi Kanaan CFA, CPA | Executive Vice President of Corporate Development and M&A |
| Hussein Omar Arkhagha | Chief People Officer |
| Susan Ringdal | Executive Vice President of Strategic Planning and Global Affairs |